Blog Posts
Nicolas Hart
Nicolas Hart/X

Nicolas Hart: CHALLENGE trial at ASCO25 – Standing Ovation for Exercise Impact on Cancer Outcomes

Nicolas Hart, Associate Professor and Program Director at University of Technology Sydney, shared a post on X:

“A standing ovation for CHALLENGE trial at ASCO25 – first in world to definitively show exercise reduces recurrence and improves survival:
‘For every 16 people, exercise prevents 1 person from recurrent/new cancer’
‘For every 14 people, exercise prevents 1 person from dying’.”

CHALLENGE trial

Read OncoDaily’s Special Articles about ASCO 2025:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

ASCO

ASCO ASCO 2025 ASCO25 cancer CHALLENGE trial Nicolas Hart OncoDaily Oncology